Positive swabs in New South Wales

10:29 PM 07 Jan 2014 NZDT
Comment (...) Tweet Share Email Print
Harness Racing NSW
07 January 2014
 

Harness Racing NSW has received three reports from the Australian Racing Forensic Laboratory (ARFL) that prohibited substances have been detected from the following horses at the respective meetings.

 

LITTLE GOZZO – Maitland 10 November 2013

 

ARFL has reported the presence of the prohibited substance hydrocortisone hemisuccinate in a post race sample taken from LITTLE GOZZO following its win in race 5, the Horsepower Pace conducted at Maitland on Sunday, 10 November 2013.

Trainer Mr Charles Mercieca has been advised of these findings. An inquiry will be conducted on Friday 10 January 2014 commencing at 11am.

Acting under the provisions of Australian Harness Racing Rule 183 (A), LITTLE GOZZO has been stood down until further notice.

 

DON BOSTON – Penrith 14 November 2013

 

ARFL has reported the presence of the prohibited substance furosemide in a post race sample taken from DON BOSTON following its win in race 1, the LEXUS IS 300H Pace conducted at Penrith on Thursday, 14 November 2013.

Trainer Mr Anthony Bucca has been advised of these findings. An inquiry will be conducted on Friday 10 January 2014 commencing at 1.30pm.

Acting under the provisions of Australian Harness Racing Rule 183 (A), DON BOSTON has been stood down until further notice.

 

APACHE – Penrith 3 October 2013

 

ARFL has reported the presence of the prohibited substance procaine in a post race sample taken from APACHE following its win in race 3, the D&M Concrete Competitive Stakes conducted at Penrith on Thursday, 3 October 2013.

Trainer Mr Joseph Tanti has been advised of these findings. An inquiry will be conducted on Wednesday 15 January 2014 commencing at 11am.

Acting under the provisions of Australian Harness Racing Rule 183 (A), APACHE has been stood down until further notice

Courtesy of Harness Racing NSW

Comment (...) Tweet Share Email Print

Read More News About...

Stallion Name

Next article: